Cargando…
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
Cysteinyl leukotrienes (cysLTs) are produced predominantly by cells of the innate immune system, especially basophils, eosinophils, mast cells, and monocytes/macrophages. Notwithstanding potent bronchoconstrictor activity, cysLTs are also proinflammatory consequent to their autocrine and paracrine i...
Autores principales: | Theron, A. J., Steel, H. C., Tintinger, G. R., Gravett, C. M., Anderson, R., Feldman, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058211/ https://www.ncbi.nlm.nih.gov/pubmed/24971371 http://dx.doi.org/10.1155/2014/608930 |
Ejemplares similares
-
Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010) -
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016) -
Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
por: Kanaoka, Yoshihide, et al.
Publicado: (2014) -
Cysteinyl-Leukotriene Receptors and Cellular Signals
por: Rovati, G. Enrico, et al.
Publicado: (2007) -
Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)